Nano-drug Global Market Demand, Growth, Opportunities, Top Key Players and Forecast to 2025

Press Release

The global Nano-drug market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Nano-drug market based on company, product type, end user and key regions.

This report studies the global market size of Nano-drug in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Nano-drug in these regions.
This research report categorizes the global Nano-drug market by top players/brands, region, type and end user. This report also studies the global Nano-drug market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
MerckPfizerNovartisAbbottGlaxoSmithKlineRocheSanofiEli LillyAstrazenecaJohnson & JohnsonCelgeneNovavaxStrykerGilead SciencesOSI PharmaceuticalsKadmon PharmaceuticalsSamyang BiopharmMitsubishi PharmaKaken PharmaceuticalSelecta BiosciencesPar PharmaceuticalCerulean PharmaNavidea BiopharmaceuticalsLummy

Request Free Sample Report @

Market size by ProductLiposomes
Polymeric Micelles
Solid lipid Nanoparticles
Microemulsion and Nanoemulsion
Market size by End User
Cancer and Tumors
Autoimmune Disorders

Market size by RegionNorth America
United States

The study objectives of this report are:To study and analyze the global Nano-drug market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Nano-drug market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Nano-drug companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Nano-drug submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Complete Report Details @

Table Of Contents:

1 Study Coverage1.1 Nano-drug Product1.2 Market Segments1.3 Key Manufacturers Covered1.4 Market by Type1.4.1 Global Nano-drug Market Size Growth Rate by Product
1.4.2 Liposomes
1.4.3 Polymeric Micelles
1.4.4 Solid lipid Nanoparticles
1.4.5 Microemulsion and Nanoemulsion
1.4.6 Nanosuspension
1.5 Market by End User1.5.1 Global Nano-drug Market Size Growth Rate by End User
1.5.2 Cancer and Tumors
1.5.3 Autoimmune Disorders
1.6 Study Objectives1.7 Years Considered

2 Executive Summary2.1 Global Nano-drug Market Size
2.1.1 Global Nano-drug Revenue 2014-2025
2.1.2 Global Nano-drug Sales 2014-2025
2.2 Nano-drug Growth Rate by Regions
2.2.1 Global Nano-drug Sales by Regions
2.2.2 Global Nano-drug Revenue by Regions

11 Company Profiles11.1 Merck11.1.1 Merck Company Details
11.1.2 Company Business Overview
11.1.3 Merck Nano-drug Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Merck Nano-drug Products Offered
11.1.5 Merck Recent Development
11.2 Pfizer11.2.1 Pfizer Company Details
11.2.2 Company Business Overview
11.2.3 Pfizer Nano-drug Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Pfizer Nano-drug Products Offered
11.2.5 Pfizer Recent Development
11.3 Novartis11.3.1 Novartis Company Details
11.3.2 Company Business Overview
11.3.3 Novartis Nano-drug Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Novartis Nano-drug Products Offered
11.3.5 Novartis Recent Development
11.4 Abbott11.4.1 Abbott Company Details
11.4.2 Company Business Overview
11.4.3 Abbott Nano-drug Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Abbott Nano-drug Products Offered
11.4.5 Abbott Recent Development
11.5 GlaxoSmithKline11.5.1 GlaxoSmithKline Company Details
11.5.2 Company Business Overview
11.5.3 GlaxoSmithKline Nano-drug Sales, Revenue and Gross Margin (2014-2019)
11.5.4 GlaxoSmithKline Nano-drug Products Offered
11.5.5 GlaxoSmithKline Recent Development




Partner Relations & Marketing Manager

[email protected]

Ph: +1-646-845-9349 (US)

Ph: +44 208 133 9349 (UK)